The utility of cardiopulmonary exercise testing to detect and track early-stage ischemic heart disease

Mayo Clinic Proceedings

Volumn 85, Issue 10, 2010, Pages 928-932

  Chaudhry, Sundeep ^a   Arena, Ross A ^b   Hansen, James E ^c   Lewis, Gregory D ^d   Myers, Jonathan N ^e   Sperling, Laurence S ^f   LaBudde, Brian D ^a   Wasserman, Karlman ^c  

^a Research and Development   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e STANFORD UNIVERSITY   (United States)

^f EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CASE REPORT; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; ISCHEMIC HEART DISEASE; MALE; PATIENT MONITORING; PATIENT SAFETY; ANAEROBIC THRESHOLD; BLOOD; DISEASE COURSE; EXERCISE TEST; FOLLOW UP; HEART RATE; MYOCARDIAL ISCHEMIA; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; UTILIZATION;

ADULT; ANAEROBIC THRESHOLD; CHOLESTEROL, LDL; DISEASE PROGRESSION; EXERCISE TEST; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; OXYGEN CONSUMPTION; REPRODUCIBILITY OF RESULTS;

EID: 77957955851     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2010.0183     Document Type: Article

References (21)

1. Chaudhry S, Ross A, Wasserman K, et al. Exercise-induced myocardial ischemia detected by cardiopulmonary exercise testing. Am J Cardiol. 2009;103(5):615-619.
2. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301(19):2024-2035.
3. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793-801. (Pubitemid 34987553)
4. Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ. Priniciples of Exercise Testing and Interpretation. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2005.
5. Belardinelli R, Lacalaprice F, Carle F, et al. Exercise-induced myocardial ischaemia detected by cardiopulmonary exercise testing. Eur Heart J. 2003;24(14):1304-1313.
6. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345(22):1583-1592.
7. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA. 1999;282(24):2340-2346. (Pubitemid 30013066)
8. Taylor AJ, Villines TC, Stanek EJ, et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med. 2009;361(22):2113- 2122.
9. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115(9):1082-1089.
10. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-1516.
11. Frye RL, August P, Brooks MM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503- 2515.
12. Schouten O, Kuijk JP, Flu WJ, et al. Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V pilot study). Am J Cardiol. 2009;103(7):897-901.
13. Milani RV, Lavie CJ, Spiva H. Limitations of estimating metabolic equivalents in exercise assessment in patients with coronary artery disease. Am J Cardiol. 1995;75(14):940-942.
14. Blumenthal RS, Michos ED. The HALTS trial-halting atherosclerosis or halted too early? N Engl J Med. 2009;361(22):2178-2180.
15. Kavanagh T, Mertens DJ, Hamm LF, et al. Prediction of long-term prognosis in 12,169 men referred for cardiac rehabilitation. Circulation. 2002;106(6):666-671.
16. Kavanagh T, Mertens DJ, Hamm LF, et al. Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol. 2003;42(12):2139-2143.
17. Oliveira RB, Myers J, Araujo CG, Abella J, Mandic S, Froelicher V. Maximal exercise oxygen pulse as a predictor of mortality among male veterans referred for exercise testing. Eur J Cardiovasc Prev Rehabil. 2009;16(3):358-364.
18. Stelken AM, Younis LT, Jennison SH, et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol. 1996;27(2):345-352.
19. Chaudhry S, Ross A, Wasserman K, et al. The utility of cardiopulmonary exercise testing in the assessment of suspected microvascular ischemia. Int J Cardiol. Epub 2009 Feb 23. doi:10.1016/j.ijcard.2009.01.055.
20. Sicari R, Rigo F, Cortigiani L, Gherardi S, Galderisi M, Picano E. Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries. Am J Cardiol. 2009;103(5):626-631.
21. Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med. 2009;169(9):843-850.